Wskaźniki 5-letniego przeżycia w różnych nowotworach złośliwych w 67 krajach: wyniki badania CONCORD-2

Allemani C i wsp. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). , LINK: Lancet. 2014 online (dostępny pełen tekst)

INTERPRETATION: International comparison of survival trends reveals very wide differences that are likely to be attributable to differences in access to early diagnosis and optimum treatment. Continuous worldwide surveillance of cancer survival should become an indispensable source of information for cancer patients and researchers and a stimulus for politicians to improve health policy and health-care systems.

Opracowane na podstawie: Lancet / 26 listopada 2014